AR035679A1 - Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los - Google Patents
Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de losInfo
- Publication number
- AR035679A1 AR035679A1 ARP020100030A ARP020100030A AR035679A1 AR 035679 A1 AR035679 A1 AR 035679A1 AR P020100030 A ARP020100030 A AR P020100030A AR P020100030 A ARP020100030 A AR P020100030A AR 035679 A1 AR035679 A1 AR 035679A1
- Authority
- AR
- Argentina
- Prior art keywords
- sales
- pharmaceutically acceptable
- compounds
- acid
- difluorpirrolidinil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035679A1 true AR035679A1 (es) | 2004-06-23 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020100030A AR035679A1 (es) | 2001-01-05 | 2002-01-04 | Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (ja) |
| JP (1) | JP2004520335A (ja) |
| KR (1) | KR20030066797A (ja) |
| CN (1) | CN1484642A (ja) |
| AR (1) | AR035679A1 (ja) |
| BR (1) | BR0116672A (ja) |
| CA (1) | CA2431545A1 (ja) |
| CZ (1) | CZ20031856A3 (ja) |
| DZ (1) | DZ3460A1 (ja) |
| EA (1) | EA200300770A1 (ja) |
| EC (1) | ECSP034682A (ja) |
| HR (1) | HRP20030544A2 (ja) |
| HU (1) | HUP0302528A2 (ja) |
| IL (1) | IL156138A0 (ja) |
| MX (1) | MXPA03005981A (ja) |
| NO (1) | NO20032973D0 (ja) |
| NZ (1) | NZ525821A (ja) |
| PE (1) | PE20020792A1 (ja) |
| PL (1) | PL361934A1 (ja) |
| SK (1) | SK8242003A3 (ja) |
| TW (1) | TW591023B (ja) |
| WO (1) | WO2002053561A1 (ja) |
| ZA (1) | ZA200304311B (ja) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| JP2002505254A (ja) * | 1998-02-06 | 2002-02-19 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | パロキセチン塩 |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DE60032905T2 (de) * | 1999-07-06 | 2007-10-18 | Eli Lilly And Co., Indianapolis | Selektive iglur5 rezeptorantagonisten zur behandlung der migräne |
-
2001
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Application Discontinuation
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ525821A (en) | 2004-07-30 |
| MXPA03005981A (es) | 2003-09-10 |
| CZ20031856A3 (cs) | 2003-09-17 |
| BR0116672A (pt) | 2003-09-23 |
| DZ3460A1 (fr) | 2002-07-11 |
| EP1351955A1 (en) | 2003-10-15 |
| ZA200304311B (en) | 2004-09-02 |
| TW591023B (en) | 2004-06-11 |
| PL361934A1 (en) | 2004-10-18 |
| SK8242003A3 (en) | 2004-01-08 |
| CA2431545A1 (en) | 2002-07-11 |
| HRP20030544A2 (en) | 2004-08-31 |
| HUP0302528A2 (hu) | 2003-11-28 |
| WO2002053561A1 (en) | 2002-07-11 |
| PE20020792A1 (es) | 2002-09-06 |
| EA200300770A1 (ru) | 2003-10-30 |
| KR20030066797A (ko) | 2003-08-09 |
| NO20032973L (no) | 2003-06-27 |
| NO20032973D0 (no) | 2003-06-27 |
| ECSP034682A (es) | 2003-08-29 |
| CN1484642A (zh) | 2004-03-24 |
| JP2004520335A (ja) | 2004-07-08 |
| IL156138A0 (en) | 2003-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034712A (es) | Ciclobuteno-1.2-dionas 3,4-di-substituidas como antagonistas del receptor quimiocina cxc | |
| ECSP034640A (es) | Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato | |
| ECSP056115A (es) | ANTAGONISTAS DEL RECEPTOR A2a DE 2-ALQUINIL- Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA ADENOSINA | |
| ECSP034744A (es) | Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos | |
| AR047992A1 (es) | Diaminopirimidinas como antagonistas de p2x3 y p2x2/3 | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| CY1111977T1 (el) | Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| UY29710A1 (es) | Benzimidazoles tricíclicos y su uso como moduladores de receptores metabotrópicos de glutamato | |
| PE20010205A1 (es) | Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato | |
| EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
| GT199800021A (es) | Utilizacion de antagonistas de los receptores de canabinoides centrales para la preparacion de medicamentos. | |
| EA201690033A2 (ru) | Морфинановые соединения | |
| BR0104834A (pt) | Moduladores de receptores de glucocorticóides | |
| AR028824A1 (es) | Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos. | |
| AR040278A1 (es) | Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos | |
| ECSP056192A (es) | 3-fluoro-piperidinas como antagonistas de nmda/nr2b | |
| CY1106645T1 (el) | Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος | |
| DE60120077D1 (de) | Modulatoren des Glucocorticoid-Rezeptors | |
| CL2004000769A1 (es) | Compuestos derivados del acido [2-(8,9-dioxo-2,6-diazabiciclo [5,2,o]non-1-(7)-en-2-il) alquil]fosfonico, antagonistas del receptor n-metil-d-aspartato (nmda); procedimiento de preparacion; composicion farmaceutica; y su uso para tratar desordenes va | |
| ES2156287T3 (es) | Derivados de difenilmetilen piperidina. | |
| CY1113759T1 (el) | Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
| BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
| UY26919A1 (es) | Derivados de la quinazolina como antagonistas adrenérgicos alfa - 1 | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FA | Abandonment or withdrawal |